Transforming growth factor-β1 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice.

MLA

Zhao, Ming-Ming, et al. “Transforming Growth Factor-Β1 Mediates the Beneficial Effects of Arketamine on Demyelination and Remyelination in the Brains of Cuprizone-Treated Mice.” European Journal of Pharmacology, vol. 985, Dec. 2024, p. 177096. EBSCOhost, https://doi.org/10.1016/j.ejphar.2024.177096.

APA

Zhao, M.-M., Zhu, T.-T., Xu, D., Wan, X., Liu, G., Murayama, R., Cai, Y., Yue, Y., Wang, X.-M., Yang, J.-J., & Hashimoto, K. (2024). Transforming growth factor-β1 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice. European Journal of Pharmacology, 985, 177096. https://doi.org/10.1016/j.ejphar.2024.177096

Chicago

Zhao, Ming-Ming, Ting-Ting Zhu, Dan Xu, Xiayun Wan, Guilin Liu, Rumi Murayama, Yi Cai, et al. 2024. “Transforming Growth Factor-Β1 Mediates the Beneficial Effects of Arketamine on Demyelination and Remyelination in the Brains of Cuprizone-Treated Mice.” European Journal of Pharmacology 985 (December): 177096. doi:10.1016/j.ejphar.2024.177096.